Table 6. Histopathological results among non-attendees* (intention to treat).
Telephone group Pap Smear N = 36 | Telephone Group HPV self-Sampling test N = 12 | HPV self-sampling–test group N = 57 | Summary Non-attendees with intervention N = 105 | Control group N = 14 | OR (95% conf. interval) | |
---|---|---|---|---|---|---|
Benign | 13 | 7 | 14 | 34 | 3 | Ref 1 |
LSIL | 8 | 2 | 24 | 34 | 5 | 0.6 (0.08–3.4) |
HSIL | 9 | 2 | 13 | 24 | 5 | 0.4 (0.06–2.4) |
AIS** | 1 | 1 | ||||
SCC | 5 | 5 | 10 | 1 | 0.9 (0.06–51) | |
Adeno carcinoma | 1 | 1 | ||||
Unspecified | 1 | 1 |
*Until 31 December 2017
** Adenocarcinoma in situ